A program to promote patient-delivered partner therapy increased EPT use and had a modest effect on gonorrhea and chlamydia incidence.
Expedited partner therapy (EPT), in which a patient with an identified sexually transmitted infection is given a prescription or medication for his or her sexual partner or partners, lowers chlamydia and gonorrhea reinfection rates and has been legalized in many states. To evaluate a public health intervention to promote EPT use, investigators randomized 23 health jurisdictions in Washington State to four study groups, which implemented the intervention at 6- to 8-month intervals. The intervention provided free medication at clinics or pharmacies for partners of patients with chlamydia or gonorrhea, as well as help contacting these partners if patients did not want to do so themselves (partner services).
During the 3-year study, the proporti…
Reviewing Author
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)